New Proposed Rule on Prescription Drug Transparency in Medicaid Has Been Announced

CMS released a proposed rule that impacts the Medicaid Drug Rebate Program and other Medicaid drug pricing, reimbursement, and data collection issues. Among the proposals, addressing spread pricing by pharmacy benefit managers and identification of 340B drugs on managed care pharmacy identification cards are of the most interest to FQHCs. NACHC will host office hours later this month to go over the proposed rule – details to come. Comments on the rule are due by July 25.